22,135,656
Vote Records
28,570
Companies
12,092
Funds
3,981
Managers

Home › Companies › PTC THERAPEUTICS INC. › 2024-2025

PTC THERAPEUTICS INC. 2024-2025 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and PTC THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Reported items
  • 254Asset managers, any item
  • 1,692Fund votes
  • June 17, 2025Meeting date

Results at a glance

Meeting of June 17, 2025: 3 items on PTC THERAPEUTICS INC.’s Form 8-K, filed June 17, 2025: 3 passed (calculated).

Dissent

Notable dissent: 1 director (12.2% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Tang Capital (13F, 1.8%, as of September 30, 2026)

Explore PTC THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by PTC THERAPEUTICS INC.

These tallies are PTC THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

PTC THERAPEUTICS INC. — official shareholder meeting results, meeting held June 17, 2025
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Allan Jacobson, Ph.D. 60,386,986---- 2,122,2624,966,822 97%Passed (calculated)—
Elect Director: David P. Southwell 59,200,375---- 3,308,8734,966,822 95%Passed (calculated)—
Elect Director: Alethia Young 54,894,657---- 7,614,5914,966,822 88%Passed (calculated)—

Source: PTC THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2025 — read the filing on EDGAR.

How asset managers voted at the PTC THERAPEUTICS INC. 2024-2025 meeting

254 asset managers disclosed a vote on at least one PTC THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PTC THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Allan Jacobson, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 60,386,986WITHHELD: 2,122,262
Details: description as filed, official tally, votes by 83 asset managers

Description as filed by funds: Election of Three Class III Directors: Allan Jacobson, Ph.D.

PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Allan Jacobson, Ph.D.”): 60,386,986 for, 2,122,262 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 83 asset managers below reported 23,858,651 for, 508,238 withheld, 6,538 abstained.

FOR
FOR: 23,858,651ABSTAIN: 6,538WITHHOLD: 508,238
Largest asset managers voting on “Election of Three Class III Directors: Allan Jacobson, Ph.D.” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard11,503,3930 00For
BlackRock3,017,3100 00For
Fidelity1,975,8150 00For
TIAA1,000,2970 00For
JANUS INVESTMENT FUND888,4200 00For
State Street721,9640 042For
Charles Schwab672,7530 00For
T. Rowe Price302,7090 0321,396Mixed
FRANKLIN STRATEGIC SERIES440,8110 00For
Manager Directed Portfolios372,3860 00For
Bridge Builder Trust321,5810 6,5380For
Hartford303,4680 00For
DRIEHAUS MUTUAL FUNDS225,4820 00For
Invesco212,9500 00For
Equitable121,1550 090,170Mixed
QUANTITATIVE MASTER SERIES LLC131,0120 00For
Lincoln Financial94,1840 00For
Goldman Sachs93,6450 00For
Prudential/PGIM88,0970 00For
Brighthouse44,1970 040,823Mixed
Northwestern Mutual83,5640 00For
First Trust79,9690 00For
John Hancock78,3380 00For
Federated Hermes65,9860 00For
Global X58,0180 00For

Showing the 25 largest of 83 asset managers. All 83 are in the interactive database (link above).

Elect Director: Alethia Young

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%
FOR: 54,894,657WITHHELD: 7,614,591
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Three Class III Directors: Alethia Young

PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: Alethia Young”): 54,894,657 for, 7,614,591 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 82 asset managers below reported 20,735,261 for, 3,220,761 withheld, 396,405 abstained.

FOR
FOR: 20,735,261ABSTAIN: 396,405WITHHOLD: 3,220,761
Largest asset managers voting on “Election of Three Class III Directors: Alethia Young” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard11,502,7570 0636For
BlackRock3,017,3100 00For
Fidelity1,975,8150 00For
TIAA00 01,000,297Withhold
JANUS INVESTMENT FUND888,4200 00For
State Street722,0060 00For
Charles Schwab00 0672,753Withhold
T. Rowe Price00 0624,105Withhold
FRANKLIN STRATEGIC SERIES00 0440,811Withhold
Manager Directed Portfolios00 372,3860Abstain
Bridge Builder Trust328,1190 00For
Hartford303,4680 00For
DRIEHAUS MUTUAL FUNDS225,4820 00For
Invesco00 0212,950Withhold
Equitable121,1550 090,170Mixed
QUANTITATIVE MASTER SERIES LLC131,0120 00For
Lincoln Financial94,1840 00For
Goldman Sachs93,6450 00For
Prudential/PGIM85,1870 02,910For
Brighthouse44,1970 040,823Mixed
Northwestern Mutual83,5640 00For
First Trust79,9690 00For
John Hancock62,5850 15,7530Mixed
Federated Hermes65,9860 00For
Global X00 058,018Withhold

Showing the 25 largest of 82 asset managers. All 82 are in the interactive database (link above).

Elect Director: David P. Southwell

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 59,200,375WITHHELD: 3,308,873
Details: description as filed, official tally, votes by 82 asset managers

Description as filed by funds: Election of Three Class III Directors: David P. Southwell

PTC THERAPEUTICS INC.’s own tally for this item (“Elect Director: David P. Southwell”): 59,200,375 for, 3,308,873 withheld, per its Form 8-K filed June 17, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 82 asset managers below reported 22,857,489 for, 1,487,708 withheld, 7,230 abstained.

FOR
FOR: 22,857,489ABSTAIN: 7,230WITHHOLD: 1,487,708
Largest asset managers voting on “Election of Three Class III Directors: David P. Southwell” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard11,503,3930 00For
BlackRock3,017,3100 00For
Fidelity1,975,8150 00For
TIAA00 01,000,297Withhold
JANUS INVESTMENT FUND888,4200 00For
State Street721,9640 042For
Charles Schwab672,7530 00For
T. Rowe Price302,7090 0321,396Mixed
FRANKLIN STRATEGIC SERIES440,8110 00For
Manager Directed Portfolios372,3860 00For
Bridge Builder Trust321,5810 6,5380For
Hartford303,4680 00For
DRIEHAUS MUTUAL FUNDS225,4820 00For
Invesco212,9500 00For
Equitable121,1550 090,170Mixed
QUANTITATIVE MASTER SERIES LLC131,0120 00For
Lincoln Financial94,1840 00For
Goldman Sachs93,6450 00For
Prudential/PGIM88,0970 00For
Brighthouse44,1970 040,823Mixed
Northwestern Mutual83,5640 00For
First Trust79,9690 00For
John Hancock78,3380 00For
Federated Hermes65,9860 00For
Global X58,0180 00For

Showing the 25 largest of 82 asset managers. All 82 are in the interactive database (link above).

Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

98% Fund and manager reports combined; may count the same shares twice · no official result

FOR
Details: description as filed, votes by 251 asset managers

Description as filed by funds: Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 80 asset managers voting on “Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described ” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard11,503,3930 00For
BlackRock3,017,3100 00For
Fidelity1,975,8150 00For
TIAA1,000,2970 00For
JANUS INVESTMENT FUND888,4200 00For
State Street722,0060 00For
Charles Schwab672,7530 00For
T. Rowe Price624,1050 00For
FRANKLIN STRATEGIC SERIES440,8110 00For
Manager Directed Portfolios372,3860 00For
Bridge Builder Trust328,1190 00For
Hartford303,4680 00For
DRIEHAUS MUTUAL FUNDS225,4820 00For
Invesco0212,950 00Against
Equitable211,3250 00For
QUANTITATIVE MASTER SERIES LLC131,0120 00For
Lincoln Financial94,1840 00For
Goldman Sachs93,6450 00For
Prudential/PGIM88,0970 00For
Brighthouse85,0200 00For
Northwestern Mutual83,5640 00For
First Trust79,9690 00For
John Hancock78,3380 00For
Federated Hermes65,9860 00For
Global X58,0180 00For

Fund voting reports, all 80 managers: 24,071,163 for, 269,073 against, 29,346 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 196 asset managers voting on “Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described ” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
RTW INVESTMENTS, LP7,546,4150 00For
ARMISTICE CAPITAL, LLC5,332,4880 00For
Wellington4,974,2860 00For
BlackRock3,034,8940 00For
Janus Henderson2,943,5190 00For
Fidelity2,242,1260 00For
State Street2,218,2800 00For
FRANKLIN ADVISERS INC1,228,2070 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,059,9500 00For
Nuveen1,007,6100 00For
Camber Capital Management LP960,0000 00For
PICTET ASSET MANAGEMENT SA959,2360 00For
T. Rowe Price926,3070 00For
Charles Schwab673,0120 00For
Northern Trust653,3810 00For
Hood River Capital Management LLC628,3870 00For
BNP Paribas Asset Management Holding S.A.0529,606 00Against
DE Shaw507,1010 00For
Point72442,0860 00For
ROCKEFELLER FINANCIAL LLC421,7400 00For
Renaissance417,0290 00For
Palo Alto Investors LP404,1960 00For
MARSHALL WACE, LLP342,7570 00For
MPM BioImpact LLC328,3250 00For
Man Group plc298,7630 00For

Institutional-manager reports, all 196 managers: 44,111,509 for, 1,405,731 against, 60 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for…

No official matchAUDIT-RELATED

99.9% of fund votes cast · no official result

FOR
Details: description as filed, votes by 80 asset managers

Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.

The 80 asset managers below reported 24,360,179 for, 1,057 against, 8,346 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 24,360,179AGAINST: 1,057ABSTAIN: 8,346
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING” at PTC THERAPEUTICS INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard11,503,3930 00For
BlackRock3,017,3100 00For
Fidelity1,975,8150 00For
TIAA1,000,2970 00For
JANUS INVESTMENT FUND888,4200 00For
State Street721,96442 00For
Charles Schwab672,7530 00For
T. Rowe Price624,1050 00For
FRANKLIN STRATEGIC SERIES440,8110 00For
Manager Directed Portfolios372,3860 00For
Bridge Builder Trust328,1190 00For
Hartford303,4680 00For
DRIEHAUS MUTUAL FUNDS225,4820 00For
Invesco212,9500 00For
Equitable211,3250 00For
QUANTITATIVE MASTER SERIES LLC131,0120 00For
Lincoln Financial94,1840 00For
Goldman Sachs93,6450 00For
Prudential/PGIM88,0970 00For
Brighthouse85,0200 00For
Northwestern Mutual83,5640 00For
First Trust79,9690 00For
John Hancock78,3380 00For
Federated Hermes65,9860 00For
Global X58,0180 00For

Showing the 25 largest of 80 asset managers. All 80 are in the interactive database (link above).

Largest PTC THERAPEUTICS INC. shareholders voting in 2024-2025

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 79,225,276 shares outstanding at the time of that meeting.

Fund voting reports: top PTC THERAPEUTICS INC. shareholders by shares voted on “Election of Three Class III Directors: Allan Jacobson, Ph.D.”, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 14.52%
2BlackRock 3.81%
3Fidelity 2.49%
4TIAA 1.26%
5JANUS INVESTMENT FUND 1.12%
6State Street 0.91%
7Charles Schwab 0.85%
8T. Rowe Price 0.79%
9FRANKLIN STRATEGIC SERIES 0.56%
10Manager Directed Portfolios 0.47%
Institutional-manager reports: top PTC THERAPEUTICS INC. shareholders by shares voted on “Approval on a non-binding, advisory basis, of the Company's named executive officer…”, 2024-2025
#Asset manager % of shares outstanding
1RTW INVESTMENTS, LP 9.53%
2ARMISTICE CAPITAL, LLC 6.73%
3Wellington 6.28%
4BlackRock 3.83%
5Janus Henderson 3.72%
6Fidelity 2.83%
7State Street 2.80%
8FRANKLIN ADVISERS INC 1.55%
9DRIEHAUS CAPITAL MANAGEMENT LLC 1.34%
10Nuveen 1.27%

Reported PTC THERAPEUTICS INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

PTC THERAPEUTICS INC. holdings and ownership disclosed for the 2024-2025 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group8,607,372 10.86%Form 13F, quarter ended March 31, 2025
BlackRock7,768,217 9.81%Form 13F, quarter ended March 31, 2025
RTW Investments, LP7,423,970 9.37%Proxy statement (DEF 14A), table as of April 21, 2025
JANUS HENDERSON GROUP PLC7,193,433 9.08%Schedule 13G, filed May 15, 2026
Wellington Management5,419,172 6.84%Form 13F, quarter ended March 31, 2025
Vanguard Portfolio Management4,871,329 6.15%Schedule 13G, filed April 29, 2026
Armistice Capital, LLC3,277,272 4.14%Schedule 13G, filed November 14, 2025
The Toronto-Dominion Bank3,025,945 3.82%Schedule 13G, filed May 15, 2026
State Street2,454,896 3.10%Form 13F, quarter ended March 31, 2025
FMR (Fidelity)2,013,562 2.54%Form 13F, quarter ended March 31, 2025

Percentages above are of 79,225,276 shares outstanding, as reported by PTC THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At PTC THERAPEUTICS INC.'s shareholder meeting held June 17, 2025, in the 2024-2025 proxy season, 254 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,692 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. PTC THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval on a non-binding, advisory basis, of the Company's named executive officer… — the reporting funds and managers cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PTC THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

PTC THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.

Cite this page

Proxy Votes Now, “PTC THERAPEUTICS (PTCT) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/ptc-therapeutics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.